Fierce Biotech February 21, 2024
A tiny surgical robot has picked up a large sum: Medical Microinstruments has secured $110 million in venture capital funding to help support the commercial rollout of its Symani system, with wristed instruments small enough to help surgeons suture the most delicate blood vessels and tissues.
MMI’s series C round was led by Fidelity Management & Research Company and joined by its previous backers—which include Deerfield Management, the headliner of the company’s 2022 series B financing that raised a total of $87 million, alongside Wellington Partners, BioStar Capital, RA Capital Management, Andera Partners, Fountain Healthcare Partners, Panakès Partners and Sambatech.
“Against a backdrop of plateauing investments in medical robotics, this support builds on our confidence in a new, less invasive...
Today's Sponsors
Today's Sponsor